The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CCEL · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
BICX · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | CCEL | IRTC | BICX | AMRX |
|---|---|---|---|---|
| Moat Score (0–100) | 43 (highest) | 43 (highest) | 43 (highest) | 43 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 47 | 63 | 29 | 74 (highest) |
| Pricing power | 99 (highest) | 98 | 70 | 37 |
| Returns on capital | — | 0 | — | 8 (highest) |
| Balance-sheet safety | 0 | 28 | 28 | 49 (highest) |
| Capital discipline | 24 | 24 | 44 (highest) | 44 (highest) |
| Price vs. high estimate | 526% above high estimate | No price data | No price data | No price data |
| Market cap | $28.0M | $3.6B | $6.1M | — |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |